Foamix Pharmaceuticals Ltd.
(NASDAQ : FOMX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
3.68%20.002.0%$660.42m
SHPGShire PLC Sponsored ADR
1.78%175.230.4%$147.04m
GWPHGW Pharmaceuticals PLC Sponsored ADR
2.49%146.796.8%$143.37m
PRGOPerrigo Co. Plc
1.37%72.806.8%$101.03m
JAZZJazz Pharmaceuticals Plc
1.76%158.002.2%$68.53m
ENDPEndo International Plc
4.81%18.328.9%$64.99m
MNKMallinckrodt Plc
2.28%27.8021.1%$61.76m
ICPTIntercept Pharmaceuticals, Inc.
4.93%106.5418.7%$51.65m
SAGESAGE Therapeutics, Inc.
2.89%123.729.6%$49.73m
UTHRUnited Therapeutics Corporation
2.46%126.4614.4%$37.74m
CTLTCatalent Inc
2.77%42.722.4%$34.62m
ICLRICON Plc
2.83%148.244.1%$33.74m
AERIAerie Pharmaceuticals, Inc.
5.35%59.256.9%$28.58m
PCRXPacira Pharmaceuticals, Inc.
4.04%47.1510.6%$27.67m
MDCOMedicines Company
4.57%28.1621.8%$27.27m

Company Profile

Foamix Pharmaceuticals Ltd. is a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel.